Introgen Therapeutics, Inc.Austin, TX, United States (NASDAQ (GM): INGN)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Company Description

Hoover's coverage by Kristi Park

Introgen Therapeutics is looking inward for the cancer cure. The biotech drug developer is working on gene therapies that fight cancer by...

Full Company Description for Introgen Therapeutics

Headquarters:

301 Congress Ave., Ste. 1850
Austin, TX 78701
United States  (Map)

More Introgen Therapeutics Locations & Contact Info

Key Introgen Therapeutics Financials

Company Type Public - NASDAQ (GM): INGN
Main Headquarters
Fiscal Year-End December
2007 Sales (mil.) $1.0
2005 Employees 80

More Introgen Therapeutics Financials (11 pages)

Competition

Competitive Landscape for Chemicals

Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...

Read more about Introgen Therapeutics's competition across multiple industries

Top Introgen Therapeutics Competitors

Editor-Selected Competitor List For Introgen Therapeutics

Introgen Therapeutics Executives

Title Name & Bio Contact
Chairman, President, and CEO David G. Nance Network | E-mail
CFO James W. (Jim) Albrecht Jr. Network | E-mail
SVP Operations J. David Enloe Jr. Network | E-mail

More Introgen Therapeutics Executives

Are You Listed On Hoover's?
Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record.

Network With People At Introgen Therapeutics

Tools from our advertising partners:

Sponsored Opportunity